Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476
What this trial is testing

Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05143840
What this trial is testing

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia, Chronic PhaseAdult CMLLeukemia, Myeloid+1 more
University of Alabama at Birmingham 100
Post-approval studies (Phase 4)Study completedNCT00926289
What this trial is testing

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 894
Large-scale testing (Phase 3)Ended earlyNCT00442026
What this trial is testing

Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC

Who this might be right for
Non-small-cell Lung Cancer
Hellenic Oncology Research Group 106
Large-scale testing (Phase 3)Study completedNCT01556776
What this trial is testing

Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 89
Large-scale testing (Phase 3)Study completedNCT01154140
What this trial is testing

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

Who this might be right for
Non Squamous Lung Cancer
Pfizer 343
Post-approval studies (Phase 4)Study completedNCT01041274
What this trial is testing

DECIFER: Depression and Citalopram In First Episode Recovery

Who this might be right for
SchizophreniaSchizophreniform Disorder
NYU Langone Health 95
Testing effectiveness (Phase 2)WithdrawnNCT00935558
What this trial is testing

Dendritic Cell Based Therapy for Breast Cancer Patients

Who this might be right for
Breast Cancer
Inge Marie Svane
Large-scale testing (Phase 3)Ended earlyNCT03199885
What this trial is testing

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast AdenocarcinomaMetastatic HER2-Positive Breast CarcinomaRecurrent Breast Adenocarcinoma+5 more
National Cancer Institute (NCI) 190
Large-scale testing (Phase 3)Study completedNCT03156452
What this trial is testing

Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate

Who this might be right for
Immune Thrombocytopenia
University Hospitals Bristol and Weston NHS Foundation Trust 123
Not applicableStudy completedNCT01216891
What this trial is testing

Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Research Foundation for Mental Hygiene, Inc. 65
Large-scale testing (Phase 3)Study completedNCT00211692
What this trial is testing

Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial

Who this might be right for
Chronic Hepatitis C
Minneapolis Veterans Affairs Medical Center 64
Post-approval studies (Phase 4)Not Yet RecruitingNCT06644833
What this trial is testing

Effective of Transcranial Magnetic Stimulation (TMS) vs Treatment as Usual for First-Episode Depression in Adults

Who this might be right for
Major Depressive Disorder
Sultan Qaboos University 120
Testing effectiveness (Phase 2)Looking for participantsNCT06769152
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors

Who this might be right for
Cervical CancerOvarian Cancer
Shanghai Henlius Biotech 190
Large-scale testing (Phase 3)Looking for participantsNCT07294508
What this trial is testing

Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer

Who this might be right for
HER2 + Breast Cancer
Shanghai Henlius Biotech 706
Testing effectiveness (Phase 2)UnknownNCT05509478
What this trial is testing

Lenvatinib Combined With PD-1 Inhibitors as First-line Treatment for Unresectable/Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Cancer
The First Hospital of Jilin University 46
Early research (Phase 1)UnknownNCT05088889
What this trial is testing

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Sheba Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT00138125
What this trial is testing

Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Translational Oncology Research International 2
Large-scale testing (Phase 3)WithdrawnNCT01605084
What this trial is testing

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Who this might be right for
HIV
Bristol-Myers Squibb
Not applicableUnknownNCT01756625
What this trial is testing

PREMIUM, Observational Study

Who this might be right for
First Line WT KRAS mCRC
Dr.Laurent Mineur 500
Next Page